A Study to Evaluate the Effect of Food on the Single-Dose Pharmacokinetics and a Drug-Drug Interaction Evaluation of Itraconazole and Rifampin on INCB123667 When Administered Orally to Healthy Adult Participants
A Phase 1, Open-Label Study to Evaluate the Effect of Food on the Single-Dose Pharmacokinetics and a Drug-Drug Interaction Evaluation of Itraconazole and Rifampin on INCB123667 When Administered Orally to Healthy Adult Participants
Sponsor: Incyte Corporation
This PHASE1 trial investigates Healthy Participants and is currently actively recruiting participants. Incyte Corporation leads this study, which shows 4 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
4 versions recorded-
Mar 2026 — Present [monthly]
Recruiting PHASE1
-
Dec 2025 — Mar 2026 [monthly]
Recruiting PHASE1
Status: Completed → Recruiting
-
Jul 2025 — Dec 2025 [monthly]
Completed PHASE1
Status: Not Yet Recruiting → Completed
-
May 2025 — Jul 2025 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Incyte Corporation
For direct contact, visit the study record on ClinicalTrials.gov .